Moody’s: Fosun unaffected by acquisition

Moody's Investors Service said that the proposed acquisition of Gland Pharma Ltd. (unrated) as well as a stake in Banco Comercial Portugues, SA (BCP, B1/bank deposit rating, stable) by companies related to Fosun International Ltd. will not immediately affect Fosun's Ba3 corporate family rating or the stable outlook on the rating.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.